A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
2025 · BMC Medicine · 6 citations
https://doi.org/10.1186/s12916-025-03916-3